ArticleMaterials today. Bio2025
Mitochondria transplanted adipose-derived stem cells/decellularized adipose tissue hydrogel for adipose tissue regeneration.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mitochondria-Targeted Nanotherapeutics: A Promising Strategy in Modulating Mitochondrial Function, Transfer, and Transplantation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Application of stem cells in the precise diagnosis and treatment of liver diseases.World journal of gastroenterology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipose tissue reconstruction is of significant importance for both cosmetic procedures and therapeutic interventions. Current clinical strategies, including autologous adipose tissue grafting and the application of synthetic materials, still have limitations. Decellularized adipose tissue (DAT) hydrogel in combination with adipose-derived stem cells (ADSCs), has emerged as a superior alternative, because of the abundant sources and inherent adipose regeneration capacity. Nevertheless, the therapeutic potential is constrained by the suboptimal functionality of ADSCs, due to the donor health status, long-term culture, and the post-transplantation environment in vivo. Mitochondria transplantation can enhance the proliferation, migration, differentiation, and pro-angiogenic ability of mesenchymal stem cells, thereby improving the tissue regeneration outcomes. In our research, we developed a novel soft tissue filler, mitochondria transplanted adipose-derived stem cells/decellularized adipose tissue (Mito-ADSCs/DAT) hydrogel. The constructive influence of the Mito-ADSCs/DAT hydrogel to angiogenesis and adipose tissue regeneration was validated in the nude mouse subcutaneous injection model. In vitro experiments and RNA-seq analysis were employed to elucidate the mechanism of Mito-ADSCs in improving adipose tissue regeneration. Although no significant enhancement in adipogenic differentiation was observed in vitro, the Mito-ADSCs exhibited promoted maximal respiration and spare respiratory capacity, and the glycolysis metabolism in Mito-ADSCs increased. Moreover, Mito-ADSCs demonstrated a marked increase in pro-angiogenic capability, which was corroborated by both in vitro assays and RNA-seq analysis. In general, our research demonstrated that the Mito-ADSCs/DAT hydrogel achieved ideal results in adipose tissue regeneration, emerging as a promising soft tissue filler for adipose tissue reconstruction and warranting further investigation for clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.